—Clinicians may be underestimating the cognitive burden on patients with MS, underscoring the need for more comprehensive cognitive assessments and assessing patient-reported outcomes. A growing body ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

A groundbreaking new trial is set to investigate whether an mRNA jab, designed to target the Epstein-Barr virus (EBV), could ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

—Mill Etienne, MD, of New York Medical College, describes the steps he takes when met with skepticism toward medications. "At the end of the day, it's the patient who's going to be putting this ...

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...

“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...

Before insurance plans will approve doctor-recommended medication, they often require patients to try cheaper alternatives in ...